세계의 시클로덱스트린 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 최종 용도별, 지역별 전망과 예측(2024-2031년)

The Global Cyclodextrin Market size is expected to reach $504.3 million by 2031, rising at a market growth of 5.6% CAGR during the forecast period. In the year 2023, the market attained a volume of 873.18 Tonnes, experiencing a growth of 17.7% (2020-2023).

Cyclodextrins are well-known for improving the solubility and bioavailability of poorly soluble drugs. Therefore, the pharmaceutical segment would acquire 34.8% revenue share by 2031. Moreover, the pharmaceutical segment utilized 289.62 Tonnes of Cyclodextrin in 2023. Many active pharmaceutical ingredients (APIs) have limited solubility in aqueous solutions, hindering their absorption and efficacy in pharmaceutical formulations.

Many drugs used to treat infectious diseases face challenges related to poor solubility, which can hinder their effectiveness. Cyclodextrins, with their ability to form inclusion complexes, can improve the solubility of these drugs. In addition, these increase their aqueous solubility by encapsulating poorly soluble drugs within their hydrophobic cavity, making them more bioavailable and efficacious. Thus, increasing drug formulation for infectious diseases drives the market's growth.

Additionally, as urbanization progresses and incomes rise, there's a notable shift in dietary preferences towards convenience and processed foods. These find extensive applications in the food and beverage industry as encapsulants for flavors, fragrances, and other functional ingredients. Therefore, the growing middle-class population and urbanization propel the market's growth.

However, these can uniquely form inclusion complexes with poorly soluble drugs, improving their solubility and bioavailability. This property is particularly valuable in drug delivery systems were increasing the solubility and bioavailability of active pharmaceutical ingredients (APIs) can enhance drug efficacy and therapeutic outcomes. Thus, drug delivery system innovations are propelling the market's growth.

Type Outlook

Based on type, the market is divided into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. The alpha-cyclodextrin segment attained 24.3% revenue share in the market in 2023. Alpha-cyclodextrin offers unique properties that make it particularly suitable for certain applications. Moreover, in terms of volume, the alpha-variant segment utilized 72.57 tonnes of Cyclodextrin in 2023.

End-use Outlook

On the basis of end-use, the market is segmented into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. The chemical segment held 15.4% growth rate in the market in 2023. These have a wide range of applications in the chemical industry. They are utilized as complex agents, solubilizers, stabilizers, and carriers for various chemical compounds. Moreover, in terms of volume, the chemical segment utilized 138.44 Tonnes of Cyclodextrin in 2023.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 27.1% revenue share in the market. Consumers in the Asia Pacific region is becoming increasingly aware of health and wellness trends, leading to a surge in demand for functional foods, dietary supplements, and personal care products with added health benefits. In terms of volume, the Asia Pacific region would utilize 1,22,154.38 tonnes of Cyclodextrin by 2031.

List of Key Companies Profiled

• Midas Pharma Gmbh
• Wacker Chemie AG
• Roquette Freres SA
• Cambrex Corporation
• Wellona Pharma
• Cayman Chemical Company, Inc.
• Cyclolab Kft.
• Ligand Pharmaceuticals Incorporated
• Tocopharm Co. Limited
• Merck KGaA

Global Cyclodextrin Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)

• Beta-Cyclodextrin
• Alpha-Cyclodextrin
• Gamma-Cyclodextrin

By End-use (Volume, Tonnes, USD Million, 2020-2031)

• Pharmaceutical
• Food
• Cosmetics & Personal Care
• Chemical
• Textile
• Others

By Geography (Volume, Tonnes, USD Million, 2020-2031)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Cyclodextrin Market, by Type
  • 1.4.2Global Cyclodextrin Market, by End-use
  • 1.4.3Global Cyclodextrin Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter Five Forces Analysis

Chapter 4.Global Cyclodextrin Market by Type

• 4.1Global Beta-Cyclodextrin Market by Region
• 4.2Global Alpha-Cyclodextrin Market by Region
• 4.3Global Gamma-Cyclodextrin Market by Region

Chapter 5.Global Cyclodextrin Market by End-use

• 5.1Global Pharmaceutical Market by Region
• 5.2Global Food Market by Region
• 5.3Global Cosmetics & Personal Care Market by Region
• 5.4Global Chemical Market by Region
• 5.5Global Textile Market by Region
• 5.6Global Others Market by Region

Chapter 6.Global Cyclodextrin Market by Region

• 6.1North America Cyclodextrin Market
  • 6.1.1North America Cyclodextrin Market by Type
    • 6.1.1.1North America Beta-Cyclodextrin Market by Country
    • 6.1.1.2North America Alpha-Cyclodextrin Market by Country
    • 6.1.1.3North America Gamma-Cyclodextrin Market by Country
  • 6.1.2North America Cyclodextrin Market by End-use
    • 6.1.2.1North America Pharmaceutical Market by Country
    • 6.1.2.2North America Food Market by Country
    • 6.1.2.3North America Cosmetics & Personal Care Market by Country
    • 6.1.2.4North America Chemical Market by Country
    • 6.1.2.5North America Textile Market by Country
    • 6.1.2.6North America Others Market by Country
  • 6.1.3North America Cyclodextrin Market by Country
    • 6.1.3.1US Cyclodextrin Market
      • 6.1.3.1.1US Cyclodextrin Market by Type
      • 6.1.3.1.2US Cyclodextrin Market by End-use
    • 6.1.3.2Canada Cyclodextrin Market
      • 6.1.3.2.1Canada Cyclodextrin Market by Type
      • 6.1.3.2.2Canada Cyclodextrin Market by End-use
    • 6.1.3.3Mexico Cyclodextrin Market
      • 6.1.3.3.1Mexico Cyclodextrin Market by Type
      • 6.1.3.3.2Mexico Cyclodextrin Market by End-use
    • 6.1.3.4Rest of North America Cyclodextrin Market
      • 6.1.3.4.1Rest of North America Cyclodextrin Market by Type
      • 6.1.3.4.2Rest of North America Cyclodextrin Market by End-use
• 6.2Europe Cyclodextrin Market
  • 6.2.1Europe Cyclodextrin Market by Type
    • 6.2.1.1Europe Beta-Cyclodextrin Market by Country
    • 6.2.1.2Europe Alpha-Cyclodextrin Market by Country
    • 6.2.1.3Europe Gamma-Cyclodextrin Market by Country
  • 6.2.2Europe Cyclodextrin Market by End-use
    • 6.2.2.1Europe Pharmaceutical Market by Country
    • 6.2.2.2Europe Food Market by Country
    • 6.2.2.3Europe Cosmetics & Personal Care Market by Country
    • 6.2.2.4Europe Chemical Market by Country
    • 6.2.2.5Europe Textile Market by Country
    • 6.2.2.6Europe Others Market by Country
  • 6.2.3Europe Cyclodextrin Market by Country
    • 6.2.3.1Germany Cyclodextrin Market
      • 6.2.3.1.1Germany Cyclodextrin Market by Type
      • 6.2.3.1.2Germany Cyclodextrin Market by End-use
    • 6.2.3.2UK Cyclodextrin Market
      • 6.2.3.2.1UK Cyclodextrin Market by Type
      • 6.2.3.2.2UK Cyclodextrin Market by End-use
    • 6.2.3.3France Cyclodextrin Market
      • 6.2.3.3.1France Cyclodextrin Market by Type
      • 6.2.3.3.2France Cyclodextrin Market by End-use
    • 6.2.3.4Russia Cyclodextrin Market
      • 6.2.3.4.1Russia Cyclodextrin Market by Type
      • 6.2.3.4.2Russia Cyclodextrin Market by End-use
    • 6.2.3.5Spain Cyclodextrin Market
      • 6.2.3.5.1Spain Cyclodextrin Market by Type
      • 6.2.3.5.2Spain Cyclodextrin Market by End-use
    • 6.2.3.6Italy Cyclodextrin Market
      • 6.2.3.6.1Italy Cyclodextrin Market by Type
      • 6.2.3.6.2Italy Cyclodextrin Market by End-use
    • 6.2.3.7Rest of Europe Cyclodextrin Market
      • 6.2.3.7.1Rest of Europe Cyclodextrin Market by Type
      • 6.2.3.7.2Rest of Europe Cyclodextrin Market by End-use
• 6.3Asia Pacific Cyclodextrin Market
  • 6.3.1Asia Pacific Cyclodextrin Market by Type
    • 6.3.1.1Asia Pacific Beta-Cyclodextrin Market by Country
    • 6.3.1.2Asia Pacific Alpha-Cyclodextrin Market by Country
    • 6.3.1.3Asia Pacific Gamma-Cyclodextrin Market by Country
  • 6.3.2Asia Pacific Cyclodextrin Market by End-use
    • 6.3.2.1Asia Pacific Pharmaceutical Market by Country
    • 6.3.2.2Asia Pacific Food Market by Country
    • 6.3.2.3Asia Pacific Cosmetics & Personal Care Market by Country
    • 6.3.2.4Asia Pacific Chemical Market by Country
    • 6.3.2.5Asia Pacific Textile Market by Country
    • 6.3.2.6Asia Pacific Others Market by Country
  • 6.3.3Asia Pacific Cyclodextrin Market by Country
    • 6.3.3.1China Cyclodextrin Market
      • 6.3.3.1.1China Cyclodextrin Market by Type
      • 6.3.3.1.2China Cyclodextrin Market by End-use
    • 6.3.3.2Japan Cyclodextrin Market
      • 6.3.3.2.1Japan Cyclodextrin Market by Type
      • 6.3.3.2.2Japan Cyclodextrin Market by End-use
    • 6.3.3.3India Cyclodextrin Market
      • 6.3.3.3.1India Cyclodextrin Market by Type
      • 6.3.3.3.2India Cyclodextrin Market by End-use
    • 6.3.3.4South Korea Cyclodextrin Market
      • 6.3.3.4.1South Korea Cyclodextrin Market by Type
      • 6.3.3.4.2South Korea Cyclodextrin Market by End-use
    • 6.3.3.5Singapore Cyclodextrin Market
      • 6.3.3.5.1Singapore Cyclodextrin Market by Type
      • 6.3.3.5.2Singapore Cyclodextrin Market by End-use
    • 6.3.3.6Malaysia Cyclodextrin Market
      • 6.3.3.6.1Malaysia Cyclodextrin Market by Type
      • 6.3.3.6.2Malaysia Cyclodextrin Market by End-use
    • 6.3.3.7Rest of Asia Pacific Cyclodextrin Market
      • 6.3.3.7.1Rest of Asia Pacific Cyclodextrin Market by Type
      • 6.3.3.7.2Rest of Asia Pacific Cyclodextrin Market by End-use
• 6.4LAMEA Cyclodextrin Market
  • 6.4.1LAMEA Cyclodextrin Market by Type
    • 6.4.1.1LAMEA Beta-Cyclodextrin Market by Country
    • 6.4.1.2LAMEA Alpha-Cyclodextrin Market by Country
    • 6.4.1.3LAMEA Gamma-Cyclodextrin Market by Country
  • 6.4.2LAMEA Cyclodextrin Market by End-use
    • 6.4.2.1LAMEA Pharmaceutical Market by Country
    • 6.4.2.2LAMEA Food Market by Country
    • 6.4.2.3LAMEA Cosmetics & Personal Care Market by Country
    • 6.4.2.4LAMEA Chemical Market by Country
    • 6.4.2.5LAMEA Textile Market by Country
    • 6.4.2.6LAMEA Others Market by Country
  • 6.4.3LAMEA Cyclodextrin Market by Country
    • 6.4.3.1Brazil Cyclodextrin Market
      • 6.4.3.1.1Brazil Cyclodextrin Market by Type
      • 6.4.3.1.2Brazil Cyclodextrin Market by End-use
    • 6.4.3.2Argentina Cyclodextrin Market
      • 6.4.3.2.1Argentina Cyclodextrin Market by Type
      • 6.4.3.2.2Argentina Cyclodextrin Market by End-use
    • 6.4.3.3UAE Cyclodextrin Market
      • 6.4.3.3.1UAE Cyclodextrin Market by Type
      • 6.4.3.3.2UAE Cyclodextrin Market by End-use
    • 6.4.3.4Saudi Arabia Cyclodextrin Market
      • 6.4.3.4.1Saudi Arabia Cyclodextrin Market by Type
      • 6.4.3.4.2Saudi Arabia Cyclodextrin Market by End-use
    • 6.4.3.5South Africa Cyclodextrin Market
      • 6.4.3.5.1South Africa Cyclodextrin Market by Type
      • 6.4.3.5.2South Africa Cyclodextrin Market by End-use
    • 6.4.3.6Nigeria Cyclodextrin Market
      • 6.4.3.6.1Nigeria Cyclodextrin Market by Type
      • 6.4.3.6.2Nigeria Cyclodextrin Market by End-use
    • 6.4.3.7Rest of LAMEA Cyclodextrin Market
      • 6.4.3.7.1Rest of LAMEA Cyclodextrin Market by Type
      • 6.4.3.7.2Rest of LAMEA Cyclodextrin Market by End-use

Chapter 7.Company Profiles

• 7.1Midas Pharma GmbH
  • 7.1.1Company Overview
• 7.2Wacker Chemie AG
  • 7.2.1Company Overview
  • 7.2.2Financial Analysis
  • 7.2.3Segmental and Regional Analysis
  • 7.2.4Research & Development Expenses
  • 7.2.5Recent strategies and developments:
    • 7.2.5.1Acquisition and Mergers:
  • 7.2.6SWOT Analysis
• 7.3Roquette Freres SA
  • 7.3.1Company Overview
  • 7.3.2Recent strategies and developments:
    • 7.3.2.1Partnerships, Collaborations, and Agreements:
  • 7.3.3SWOT Analysis
• 7.4Cambrex Corporation
  • 7.4.1Company Overview
  • 7.4.2SWOT Analysis
• 7.5Wellona Pharma
  • 7.5.1Company Overview
• 7.6Cayman Chemical Company, Inc.
  • 7.6.1Company Overview
  • 7.6.2SWOT Analysis
• 7.7Cyclolab Kft.
  • 7.7.1Company Overview
• 7.8Ligand Pharmaceuticals Incorporated
  • 7.8.1Company Overview
  • 7.8.2Financial Analysis
  • 7.8.3Research & Development Expenses
• 7.9Tocopharm Co. Limited
  • 7.9.1Company Overview
• 7.10.Merck KGaA
  • 7.10.1Company Overview
  • 7.10.2Financial Analysis
  • 7.10.3Segmental and Regional Analysis
  • 7.10.4Research & Development Expense
  • 7.10.5SWOT Analysis

Chapter 8.Winning Imperatives of Cyclodextrin Market